Blocking polyamine synthesis using ODC inhibitor difluoromethylornithine (DFMO) in CRC cell lines has been shown to inhibit cell proliferation and increase apoptosis, proving the importance of suppressing ODC in CRC treatment [26]. This evidence concerns the gene ODC1 and colorectal carcinoma.